Rinshō shinkeigaku Clinical neurology最新文献

筛选
英文 中文
シンポジウム7 ALSの研究・治療はどこまできたか 座長の言葉 7als的研究和治疗研讨会到什么程度了?
Rinshō shinkeigaku Clinical neurology Pub Date : 1900-01-01 DOI: 10.5692/CLINICALNEUROL.48.965
博 三本, 元 祖父江
{"title":"シンポジウム7 ALSの研究・治療はどこまできたか 座長の言葉","authors":"博 三本, 元 祖父江","doi":"10.5692/CLINICALNEUROL.48.965","DOIUrl":"https://doi.org/10.5692/CLINICALNEUROL.48.965","url":null,"abstract":"","PeriodicalId":371642,"journal":{"name":"Rinshō shinkeigaku Clinical neurology","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127579470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
シンポジウム4 アルツハイマー病の診断と治療開発 オーバービュー 研讨会4阿尔茨海默病的诊断与治疗发展回顾
Rinshō shinkeigaku Clinical neurology Pub Date : 1900-01-01 DOI: 10.5692/CLINICALNEUROL.49.837
康夫 井原, 幸市 岡本
{"title":"シンポジウム4 アルツハイマー病の診断と治療開発 オーバービュー","authors":"康夫 井原, 幸市 岡本","doi":"10.5692/CLINICALNEUROL.49.837","DOIUrl":"https://doi.org/10.5692/CLINICALNEUROL.49.837","url":null,"abstract":"","PeriodicalId":371642,"journal":{"name":"Rinshō shinkeigaku Clinical neurology","volume":"154 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116225358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
シンポジウム11 脳梗塞臨床の第一線における問題点:Branch atheromatous disease(BAD)をどう考え,どう対処するか ねらい 研讨会11脑梗塞临床第一线的问题:如何看待Branch atheromatous disease (BAD),如何应对
Rinshō shinkeigaku Clinical neurology Pub Date : 1900-01-01 DOI: 10.5692/CLINICALNEUROL.50.913
誠治 高木
{"title":"シンポジウム11 脳梗塞臨床の第一線における問題点:Branch atheromatous disease(BAD)をどう考え,どう対処するか ねらい","authors":"誠治 高木","doi":"10.5692/CLINICALNEUROL.50.913","DOIUrl":"https://doi.org/10.5692/CLINICALNEUROL.50.913","url":null,"abstract":"","PeriodicalId":371642,"journal":{"name":"Rinshō shinkeigaku Clinical neurology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125812736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
シンポジウム8 Neuromyelitis Optica(NMO) オーバービュー 研讨会8 Neuromyelitis Optica (NMO)回顾
Rinshō shinkeigaku Clinical neurology Pub Date : 1900-01-01 DOI: 10.5692/CLINICALNEUROL.49.893
一男 藤原, G. Brian
{"title":"シンポジウム8 Neuromyelitis Optica(NMO) オーバービュー","authors":"一男 藤原, G. Brian","doi":"10.5692/CLINICALNEUROL.49.893","DOIUrl":"https://doi.org/10.5692/CLINICALNEUROL.49.893","url":null,"abstract":"","PeriodicalId":371642,"journal":{"name":"Rinshō shinkeigaku Clinical neurology","volume":"185 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131563342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
シンポジウム9 ヒト中枢神経のfunctional connectivityの新しい解析法 ねらい 研讨会9人类中枢神经的functional connectivity的新解析法
Rinshō shinkeigaku Clinical neurology Pub Date : 1900-01-01 DOI: 10.5692/clinicalneurol.50.897
義一 宇川, 秀直 福山
{"title":"シンポジウム9 ヒト中枢神経のfunctional connectivityの新しい解析法 ねらい","authors":"義一 宇川, 秀直 福山","doi":"10.5692/clinicalneurol.50.897","DOIUrl":"https://doi.org/10.5692/clinicalneurol.50.897","url":null,"abstract":"","PeriodicalId":371642,"journal":{"name":"Rinshō shinkeigaku Clinical neurology","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133657271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of continuity and precise control of taking oral antithrombotic agents with cerebrovascular disease 脑血管病患者口服抗栓药物连续性和精准控制的重要性
Rinshō shinkeigaku Clinical neurology Pub Date : 1900-01-01 DOI: 10.5692/CLINICALNEUROL.51.436
Yasuyuki Ito, Yoichiro Hashimoto
{"title":"Importance of continuity and precise control of taking oral antithrombotic agents with cerebrovascular disease","authors":"Yasuyuki Ito, Yoichiro Hashimoto","doi":"10.5692/CLINICALNEUROL.51.436","DOIUrl":"https://doi.org/10.5692/CLINICALNEUROL.51.436","url":null,"abstract":"(臨床神経 2011;51:436) 2011 年 3 月 3日 拝啓 先に本誌第 51 巻 1号に掲載された「虚血性脳血管障害発症 前の抗血栓薬内服状況の検討」 (臨床神経 2011;51:35-37) に対し池田 憲先生からご意見とご質問をいただき有難うご ざいました. 虚血性脳血管障害発症時のワルファリン内服患者は 21 名 (初発 9例,再発 12 例),男性 15 例,女性 6例,平均年齢 74.1± 10.3 歳(58~93 歳,中央値 75.5 歳)で,臨床病型は心原性脳 塞栓症が 15 例(TIA3 例をふくむ)と大部分でした.発症時 PT-INR は平均 1.78±1.33(0.95~7.27,中央値 1.34)で,PTINR≧1.6 は 7 例に過ぎず,さらに推奨 PT-INR(70 歳未満 2.0~3.0,70 歳以上 1.6~2.6)だったのは 5例のみでした(2 例は 70 歳未満で 1.6≦PT-INR<2.0).70 歳以上で推奨 PTINR 1.6~2.6 でも,2例の発症時 PT-INR は 1.78,1.73 と,1.6~ 2.0 で発症していました. 一方,初発・再発の別では初発群 182 例,再発群 84 例で, 年齢は初発群 72.9±11.4 歳,再発群 75.0±11.5 歳,男女比は初 発群 99 例:83 例,再発群 55 例:29 例でしたが,発症年齢・ 性別に関して両群間に有意差はありませんでした(p=0.245, p=0.089).また,心血管危険因子では高血圧は再発群で多い 傾向がありましたが有意差はなく(p=0.057),糖尿病,脂質 異常症,喫煙,冠動脈疾患・末梢動脈疾患の既往いずれも有意 差はありませんでした.なお,初回脳梗塞の臨床病型は初回発 症時当科へ入院した患者が少なく,検討できませんでした. 再発群について,池田らの報告では再発例は全体の 19.3% ですが,われわれの検討では 31.6%でした.また,臨床病型 について,池田らの報告ではラクナ梗塞 35%,アテローム血 栓性脳梗塞 13%ですが,われわれの検討ではそれぞれ 19%, 26%と逆転しています.一方,久山町研究では初発から 1 年間に 10%,10 年間で 50%が再発しますが,池田らの報告に ある初発から再発までの平均期間 3.1 年をふくめ初発から 5 年程度までは後者が前者の 2倍程度再発しやすくなっていま す.池田ら,われわれいずれの報告でもワルファリンコント ロールは不良であったことから,再発群の比率の違いは患者 層の違いにあり,アテローム血栓性脳梗塞患者が多かったわ れわれの検討で再発率が高値であったと考えます.池田らと われわれの検討では再発群の頻度がことなり,いずれも一施 設の検討で両者ともバイアスが掛かっている可能性があるた め,今後,地域連携パスなどを使い,多施設でデータを出す仕 組みが必要と考えます. 池田らが述べているように,再発予防には抗血栓薬内服継 続,心房細動患者ではワルファリン内服,ワルファリン内服患 者では至適治療域内での厳格なコントロールが重要で,全国 規模で医療関係者と患者の双方へ啓発をおこなう必要がある と思っています. 敬具","PeriodicalId":371642,"journal":{"name":"Rinshō shinkeigaku Clinical neurology","volume":"223 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133886126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Description of polymorphonuclear leukocyte in Japanese 日本人多形核白细胞的描述
Rinshō shinkeigaku Clinical neurology Pub Date : 1900-01-01 DOI: 10.5692/CLINICALNEUROL.49.195
J. Kira
{"title":"Description of polymorphonuclear leukocyte in Japanese","authors":"J. Kira","doi":"10.5692/CLINICALNEUROL.49.195","DOIUrl":"https://doi.org/10.5692/CLINICALNEUROL.49.195","url":null,"abstract":"","PeriodicalId":371642,"journal":{"name":"Rinshō shinkeigaku Clinical neurology","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133158391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
シンポジウム7 パーキンソン病の病因・診断・治療研究の進歩 オーバービュー 研讨会7帕金森病的病因、诊断、治疗研究进展回顾
Rinshō shinkeigaku Clinical neurology Pub Date : 1900-01-01 DOI: 10.5692/CLINICALNEUROL.49.881
美邦 水野, 智善 近藤
{"title":"シンポジウム7 パーキンソン病の病因・診断・治療研究の進歩 オーバービュー","authors":"美邦 水野, 智善 近藤","doi":"10.5692/CLINICALNEUROL.49.881","DOIUrl":"https://doi.org/10.5692/CLINICALNEUROL.49.881","url":null,"abstract":"","PeriodicalId":371642,"journal":{"name":"Rinshō shinkeigaku Clinical neurology","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122970201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
シンポジウム1 脳梗塞UP TO DATE オーバービュー 研讨会1脑梗塞UP TO DATE overview
Rinshō shinkeigaku Clinical neurology Pub Date : 1900-01-01 DOI: 10.5692/CLINICALNEUROL.49.797
幸人 篠原, 康二 阿部
{"title":"シンポジウム1 脳梗塞UP TO DATE オーバービュー","authors":"幸人 篠原, 康二 阿部","doi":"10.5692/CLINICALNEUROL.49.797","DOIUrl":"https://doi.org/10.5692/CLINICALNEUROL.49.797","url":null,"abstract":"","PeriodicalId":371642,"journal":{"name":"Rinshō shinkeigaku Clinical neurology","volume":"85 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114775289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
シンポジウム4 多発性硬化症の病態と治療:臨床と基礎の最前線 座長の言葉:多発性硬化症の分子標的療法の時代を迎えて 研讨会4多发性硬化症的病理与治疗:临床与基础前沿主席讲话:迎接多发性硬化症分子靶向疗法时代
Rinshō shinkeigaku Clinical neurology Pub Date : 1900-01-01 DOI: 10.5692/CLINICALNEUROL.48.930
潤一 吉良, 明生 錫村
{"title":"シンポジウム4 多発性硬化症の病態と治療:臨床と基礎の最前線 座長の言葉:多発性硬化症の分子標的療法の時代を迎えて","authors":"潤一 吉良, 明生 錫村","doi":"10.5692/CLINICALNEUROL.48.930","DOIUrl":"https://doi.org/10.5692/CLINICALNEUROL.48.930","url":null,"abstract":"","PeriodicalId":371642,"journal":{"name":"Rinshō shinkeigaku Clinical neurology","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129149944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信